Search
Please see below for a list of search results.
This document describes the HTA’s policy on the management and traceability of tissue samples retained by independent pathologists when undertaking post mortem examinations (PME) at HTA-licensed premises where they are not employed.
The aims of this policy are:
Today the Department of Health (DH) has published the Government’s response to the consultation on Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2017.
The HTA was asked to provide information on the traceability requirements of organs that are sent to, or received from, a country which is not in the European Union.
Since the implementation of the updated Codes of Practice and licensing standards in April 2017, there has been an increase in the amount and severity of shortfalls identified during routine site visit inspections, p